The Anlon Healthcare IPO has opened for subscription on August 26, 2025, and can shut on August 29, 2025. With a worth band of ₹86 to ₹91 per share and a complete challenge measurement of ₹121.03 crores, the IPO has attracted important consideration from each institutional and retail traders. On this article, we are going to observe the subscription standing, Gray Market Premium (GMP), itemizing expectations, and general IPO evaluation, so traders could make an knowledgeable determination on whether or not to subscribe or keep away from.
IPO Difficulty Particulars
- IPO Date: August 26, 2025 to August 29, 2025
- Value Band: ₹86 to ₹91 per share
- Lot Dimension: 164 shares (Minimal funding ₹14,924)
- Complete Difficulty Dimension: ₹121.03 Crores (1.33 crore shares)
- Difficulty Sort: 100% Recent Difficulty
- Itemizing: BSE, NSE
- Tentative Itemizing Date: September 3, 2025
IPO Reservation:
- QIB: Not lower than 75%
- NII: Not lower than 15%
- Retail: No more than 10%
You possibly can verify our earlier article about detailed Evaluate on Anlon Healthcare IPO.
Anlon Healthcare IPO Subscription Standing
Subscription standing is a vital indicator of investor demand. (We’ll replace this part as each day subscription knowledge is launched by exchanges.)
As of Day 1 (August 26, 2025):
- QIBs: [To be updated]
- NIIs: [To be updated]
- Retail: [To be updated]
- Complete Subscription: [To be updated]
Word: A powerful subscription in QIB and NII classes normally alerts greater itemizing features.
Gray Market Premium (GMP) Replace
The Gray Market Premium (GMP) displays the unofficial premium at which IPO shares are traded earlier than itemizing. As of the most recent replace:
- Anlon Healthcare IPO GMP: Round ₹20-25 per share
- Estimated Itemizing Value: ₹111 to ₹116 (towards the higher band of ₹91)
- Anticipated Itemizing Acquire: 20-25%
👉 A secure or rising GMP until the time limit typically signifies sturdy itemizing potential.
Elements Supporting Sturdy Itemizing
- Engaging Valuation – P/E of 14.26x vs. business common of 28x.
- Sturdy Monetary Efficiency – PAT grew from ₹5.82 Cr in FY23 to ₹11.96 Cr (10M FY25).
- Diversified Product Portfolio – 65 commercialized merchandise and a number of DMF approvals.
- Optimistic GMP Tendencies – Indicating wholesome investor curiosity.
Key Dangers That Could Influence Itemizing
- Excessive Competitors – Bigger API gamers like Divi’s Laboratories take pleasure in stronger model recognition.
- Low Retail Quota – With solely 10% reserved, retail demand could overshoot availability, resulting in disappointment in allotment.
- Regulatory Hurdles – Pharma enterprise is extremely depending on well timed approvals and compliance.
Verify Anlon Healthcare IPO – Key Strenghts, Dangers and Longterm Prospects
Itemizing Expectations
Contemplating the enticing pricing, sturdy fundamentals, and present GMP tendencies, the IPO is prone to checklist at a premium of 20–25% over the problem worth. Nevertheless, sustained efficiency post-listing will depend upon quarterly outcomes, regulatory updates, and execution of enlargement plans.
Conclusion
The Anlon Healthcare IPO is gaining traction with traders attributable to its sturdy financials, aggressive valuations, and rising market presence. GMP tendencies and anticipated oversubscription recommend wholesome itemizing features. For traders in search of short-term itemizing earnings, this IPO seems enticing. Lengthy-term traders ought to weigh the enterprise strengths towards dangers like regulatory dependence and dealing capital wants.
FAQs
1. What’s the Anlon Healthcare IPO GMP in the present day?
Presently, the GMP is round ₹20-25 per share.
2. When will Anlon Healthcare IPO shares be listed?
Tentative itemizing date is September 3, 2025.
3. How a lot is the retail quota in Anlon Healthcare IPO?
No more than 10% of the overall challenge measurement.
4. What’s the anticipated itemizing achieve of Anlon Healthcare IPO?
Analysts count on round 20-25% itemizing achieve primarily based on present GMP.
5. Is Anlon Healthcare IPO good for short-term traders?
Sure, subscription demand and GMP point out sturdy itemizing prospects.
6. What’s the IPO worth band?
₹86 to ₹91 per share.
7. How can traders apply for this IPO?
By ASBA in internet banking or through UPI on buying and selling apps like Zerodha, Groww, and Paytm Cash.
Disclaimer:
This text is for informational functions solely and shouldn’t be thought of as funding recommendation or a advice to subscribe/keep away from any IPO. Traders ought to rigorously learn the Purple Herring Prospectus (RHP) and seek the advice of their monetary advisor earlier than making any funding determination. The creator and web site usually are not accountable for any monetary features or losses incurred by appearing on this info.
Uncover extra from Myinvestmentideas.com
Subscribe to get the most recent posts despatched to your electronic mail.
